Health Spotlight's IgA Nephropathy
Your patient and practitioner news, research and digital healthcare source
I consent to receive newsletters via email. Terms of Use and Privacy Policy.
Critical advancements in IgAN treatments and understanding of risk factors.
Breakthroughs, management options, and the impact of kidney disease on reproductive health
Biogen's Phase 2 Success, Oxford Classification for Pediatric Outcomes, and Nefecon's Long-term Management Potential.
Significant funding milestones for IgA nephropathy gene therapy and, innovative predictive tools for paediatric care
